Literature DB >> 24078095

Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein.

Ying Cui, Lihui Zheng, Ming Jiang, Ru Jia, Xiao Zhang, Qishan Quan, Guiqin Du, Dongjin Shen, Xiaodan Zhao, Wenying Sun, Hongwei Xu, Lijuan Huang.   

Abstract

Microparticles (MPs) are vesicles released from activated or apoptotic cells. MP derive from various cells, most notably platelets, but also leucocytes, lymphocytes, erythrocytes, and endothelial cells. The aim of this study was to investigate endothelial MP (EMP), platelet MP (PMP), lymphocyte MP and monocyte MP and TF-positive MPs (TF+ MPs) in patients with coronary heart disease (CHD), and to evaluate the correlation of these MPs with Interleukin-6 (IL-6) and C-reactive protein (CRP). Different cell-derived MPs and TF+ MPs were analyzed by flow cytometry in 40 patients with myocardial infarction (MI), 30 unstable angina (UA), 20 stable angina (SA) and 20 healthy individuals, and IL-6 and CRP were determined by ELISA and special protein analyzer, respectively. Compared with SA and control, EMP and PMP was significantly elevated in MI and UA (P < 0.001), and TF+ MPs was significantly elevated in MI and UA (P < 0.001). EMP and PMP correlated with IL-6 (r = 0.822, P < 0.001 and r = 0.567, P < 0.001; respectively) or CRP level (r = 0.597, P < 0.001 and r = 0.66, P < 0.001; respectively). Different cell-derived MPs in CHD may indicate the different pathophysiological changes in vessels, and MPs may both participate in the development of thrombosis and enhance the vascular inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078095     DOI: 10.1007/s11033-013-2758-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  16 in total

Review 1.  Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?

Authors:  Maarten E Tushuizen; Michaela Diamant; Augueste Sturk; Rienk Nieuwland
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01       Impact factor: 8.311

2.  Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.

Authors:  Elena I Sinauridze; Dmitry A Kireev; Nadezhda Y Popenko; Aleksei V Pichugin; Mikhail A Panteleev; Olga V Krymskaya; Fazoil I Ataullakhanov
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

3.  Circulating microparticles and endogenous estrogen in newly menopausal women.

Authors:  M Jayachandran; R D Litwiller; W G Owen; V M Miller
Journal:  Climacteric       Date:  2009-04       Impact factor: 3.005

4.  C-Reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4-dependent NO formation.

Authors:  Jie-Mei Wang; Yan Wang; Jun-Yi Huang; Zhen Yang; Long Chen; Li-Chun Wang; An-Li Tang; Zhou-Fen Lou; Jun Tao
Journal:  J Vasc Res       Date:  2007-03-09       Impact factor: 1.934

5.  Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

Authors:  Hidenobu Koga; Seigo Sugiyama; Kiyotaka Kugiyama; Keisuke Watanabe; Hironobu Fukushima; Tomoko Tanaka; Tomohiro Sakamoto; Michihiro Yoshimura; Hideaki Jinnouchi; Hisao Ogawa
Journal:  J Am Coll Cardiol       Date:  2005-05-17       Impact factor: 24.094

6.  Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men.

Authors:  Julio A Chirinos; Juan P Zambrano; Salim S Virani; Joaquin J Jimenez; Wenche Jy; Eugene Ahn; Lawrence L Horstman; Agustin Castellanos; Robert J Myerburg; Yeon S Ahn
Journal:  Am J Cardiol       Date:  2005-05-15       Impact factor: 2.778

Review 7.  Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis.

Authors:  E Shantsila; P W Kamphuisen; G Y H Lip
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

8.  Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.

Authors:  E Biró; K N Sturk-Maquelin; G M T Vogel; D G Meuleman; M J Smit; C E Hack; A Sturk; R Nieuwland
Journal:  J Thromb Haemost       Date:  2003-12       Impact factor: 5.824

9.  Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome.

Authors:  Abdelali Agouni; Anne Hélène Lagrue-Lak-Hal; Pierre Henri Ducluzeau; Hadj Ahmed Mostefai; Catherine Draunet-Busson; Georges Leftheriotis; Christophe Heymes; Maria Carmen Martinez; Ramaroson Andriantsitohaina
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

10.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

Authors:  Arun S Shet; Omer Aras; Kalpna Gupta; Mathew J Hass; Douglas J Rausch; Nabil Saba; Louann Koopmeiners; Nigel S Key; Robert P Hebbel
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

View more
  17 in total

1.  A Meta-Analysis of Circulating Microvesicles in Patients with Myocardial Infarction.

Authors:  Zhida Wang; Wang Cai; Shaolan Hu; Yufei Xia; Yao Wang; Qi Zhang; Liming Chen
Journal:  Arq Bras Cardiol       Date:  2017-07-10       Impact factor: 2.000

2.  Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome.

Authors:  Melvin George; M R Ganesh; Aruna Sridhar; Amrita Jena; Muthukumar Rajaram; Elangovan Shanmugam; V E Dhandapani
Journal:  J Clin Diagn Res       Date:  2015-12-01

3.  Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes.

Authors:  Chenghui Zhang; Qing Ou; Yan Gu; Gaiping Cheng; Rong Du; Li Yuan; Ruth Lm Cordiner; Deying Kang; Jiaying Zhang; Qiaorong Huang; Chuan Yu; Li Kang; Xuan Wang; Xin Sun; Xianming Mo; Haoming Tian; Ewan R Pearson; Wentong Meng; Sheyu Li
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-31       Impact factor: 3.168

Review 4.  Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis.

Authors:  Lina Badimon; Rosa Suades; Eduardo Fuentes; Iván Palomo; Teresa Padró
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

5.  Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction.

Authors:  Ze-Bang Lin; Hong-Bo Ci; Yan Li; Tian-Pu Cheng; Dong-Hong Liu; Yan-Sheng Wang; Jun Xu; Hao-Xiang Yuan; Hua-Ming Li; Jing Chen; Li Zhou; Zhi-Ping Wang; Xi Zhang; Zhi-Jun Ou; Jing-Song Ou
Journal:  J Transl Med       Date:  2017-01-04       Impact factor: 5.531

Review 6.  Platelet-Derived Microvesicles in Cardiovascular Diseases.

Authors:  Maria T K Zaldivia; James D McFadyen; Bock Lim; Xiaowei Wang; Karlheinz Peter
Journal:  Front Cardiovasc Med       Date:  2017-11-21

7.  Platelet microvesicles are associated with the severity of coronary artery disease: comparison between peripheral and coronary circulation.

Authors:  E Gkaliagkousi; E Gavriilaki; E Yiannaki; I Vasileiadis; B Nikolaidou; A Lazaridis; P Dolgyras; S Grigoriadis; A Triantafyllou; P Anyfanti; D Markala; I Zarifis; S Douma
Journal:  J Thromb Thrombolysis       Date:  2020-10-11       Impact factor: 2.300

8.  Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots.

Authors:  Laily D Zubairova; Roza M Nabiullina; Chandrasekaran Nagaswami; Yuriy F Zuev; Ilshat G Mustafin; Rustem I Litvinov; John W Weisel
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

9.  Protective effects of circulating microvesicles derived from myocardial ischemic rats on apoptosis of cardiomyocytes in myocardial ischemia/reperfusion injury.

Authors:  Yao Wang; Su Wei; Yi-Lu Wang; Miao Liu; Man Shang; Qi Zhang; Yan-Na Wu; Ming-Lin Liu; Jun-Qiu Song; Yan-Xia Liu
Journal:  Oncotarget       Date:  2017-04-26

10.  Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release.

Authors:  Audrey Benyamine; Jérémy Magalon; Florence Sabatier; Luc Lyonnet; Stéphane Robert; Chloé Dumoulin; Sophie Morange; Karin Mazodier; Gilles Kaplanski; Martine Reynaud-Gaubert; Pascal Rossi; Françoise Dignat-George; Brigitte Granel; Pascale Paul
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.